Stefan Evers

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 271 citations · Full text

The vanB Gene Confers Various Levels of Self-Transferable Resistance to Vancomycin in Enterococci

Richard Quintiliani, Stefan Evers, Patrice Courvalin · The Journal of Infectious Diseases · 1993 · 154 citations

Medical Microbiology, Antimicrobial Resistance Gene, Antimicrobial Susceptibility +14

Gene Expression Changes Triggered by Exposure of <i>Haemophilus influenzae</i> to Novobiocin or Ciprofloxacin: Combined Transcription and Translation Analysis

Hans Gmuender, Karin Kuratli, Karin Di Padova et al. · Genome Research · 2001 · 154 citations · Full text

Two-dimensional map of the proteome ofHaemophilus influenzae

Hanno Langen, Béla Takács, Stefan Evers et al. · Electrophoresis · 2000 · 148 citations

Biology, Biochemistry, Biomolecular Structure Prediction +13

Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance Development

Christian Apfel, Hans H. Locher, Stefan Evers et al. · Antimicrobial Agents and Chemotherapy · 2001 · 126 citations · Full text

Bioorganic Chemistry, Peptide Engineering, Antibacterial Activity +19